Previous work has shown that male 3xTg‐AD mice do not consistently develop the hallmark AD neuropathologies including amyloidosis and hyperphosphorylated tau (Dave et al. 2023; Winslow et al. 2021; Dennison et al. 2021; Barber et al. 2024). The gene discussed is MAPT; the disease is Alzheimer disease.